8-K//Current report
Mirati Therapeutics, Inc. 8-K
Accession 0001193125-21-202150
CIK 0001576263operating
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 5:02 PM ET
Size
138.8 KB
Accession
0001193125-21-202150
Documents
- 8-Kd167100d8k.htmPrimary
8-K
- EX-101.SCHmrtx-20210625.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABmrtx-20210625_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREmrtx-20210625_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLd167100d8k_htm.xml
IDEA: XBRL DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001193125-21-202150-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
Mirati Therapeutics, Inc.
CIK 0001576263
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001576263
Filing Metadata
- Form type
- 8-K
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 5:02 PM ET
- Size
- 138.8 KB